Deal Ends Today·Save 35% annual plan
Sympathomimetic amine / anti-obesity agent (DEA Schedule IV)Reviewed for 2026 plan year

Does UPMC Health Plan Cover Phentermine (Adipex-P / Lomaira)?

The verdict

Conditional on most plans

UPMC Health Plan covers phentermine only when the specific plan includes a weight-loss or anti-obesity-medication benefit; plans with an AOM carve-out exclude it entirely, and standard Medicare Part D excludes it by statute. A Pennsylvania-specific development: PA Medicaid dropped adult weight-loss GLP-1 coverage in 2025, signaling a restrictive weight-loss climate in the state — though oral non-incretin agents like generic phentermine may be treated more favorably on the PDL than injectable GLP-1s. Phentermine is FDA-approved only for short-term use (~12 weeks) and is a DEA Schedule IV controlled substance. At $10–$40 for the generic, cash is often the fastest and cheapest path. UPMC cells are representative composites; verify on UPMC's member drug-search tool.

MedicareNot Covered
CommercialConditional
See the difference

Coverage is set by your specific plan and formulary. This is a research summary — always confirm with UPMC Health Plan using your member ID.

Reviewed for 2026
Checked against the active plan year
Sourced from formularies
UPMC Health Plan drug lists + CMS guidance
Updated as rules change
Coverage and prior-auth criteria shift often
Verify before you decide
Informational only — not insurance advice

Key facts

  • Pennsylvania Medicaid dropped adult weight-loss GLP-1 coverage in 2025, tightening the state's AOM landscape.

    CMS Medicaid drug coverage reporting / UPMC for You PDL updates, 2025

  • Generic phentermine costs approximately $10–$40 per month cash — the least expensive FDA-approved weight-loss prescription in this cluster.

    GoodRx / SingleCare cash-price data, 2026

  • Medicare Part D has statutorily excluded weight-loss agents, including phentermine, since 2006. The 2026 GLP-1 Bridge does not include phentermine.

    CMS.gov / Medicare.gov GLP-1 Bridge fact sheet

Plan types

Medicare vs. commercial coverage

Whether UPMC Health Plan covers Phentermine (Adipex-P / Lomaira) depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.

Medicare

Part D & Advantage plans

Not Covered

Medicare Part D statutorily excludes phentermine as a weight-loss agent. This applies to UPMC's Medicare Advantage and Part D plans. Phentermine is NOT included in the 2026 Medicare GLP-1 Bridge (July 1, 2026 – December 31, 2027), which covers only specified injectable weight-loss GLP-1s — Wegovy formulations, Foundayo, and the Zepbound KwikPen. Generic phentermine at $10–$40 cash is the operative route for Medicare beneficiaries; manufacturer copay cards are unavailable under federal anti-kickback rules.

Commercial / Employer

Group & marketplace plans

Conditional

UPMC commercial and employer plans cover phentermine only when the employer group has elected a weight-loss or AOM benefit — many have not. Where covered, generic phentermine is typically the lowest-cost formulary option among anti-obesity agents and may be a required step before GLP-1 approval. Prior authorization where applied: BMI of 30 or higher, or 27 or higher with a qualifying comorbidity; DEA Schedule IV quantity limits; short-term (~12 weeks) approvals. ACA marketplace plans administered by UPMC are frequently more restrictive and often exclude AOM. Pennsylvania Medicaid (UPMC for You Medicaid): PA Medicaid dropped adult weight-loss GLP-1 coverage in 2025, reflecting a tightening state-level posture. Generic phentermine as a non-incretin oral agent may receive different treatment than injectable GLP-1s on the PA Medicaid PDL — but confirm the current PA HealthChoices PDL before assuming coverage. All figures are representative composites; verify on UPMC's drug-search tool.

Prior authorization

The 4 boxes you must tick to get approved

Commercial plans that will consider Phentermine (Adipex-P / Lomaira) require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.

Requirements you meet0 / 4

Meet all 4 and you have a documented case for approval. Missing any one is the most common reason requests are denied.

What you'll pay

Your cost, three ways

What Phentermine (Adipex-P / Lomaira) actually costs you swings enormously depending on how it's covered. Here's the realistic range.

No coverage

Paying cash

Generic phentermine: approximately $40 retail per month, as low as $10 with a discount coupon (GoodRx / SingleCare). Brand Adipex-P and Lomaira are more expensive; the generic is the near-universal fill.

List price with no coverage — before any manufacturer savings card.

PA approved

With coverage

Where phentermine is covered under a UPMC commercial or AOM-benefit plan, generic tier co-pays are typically $0–$15 per month. Confirm your specific tier on the UPMC member portal.

Typical monthly copay once prior authorization is approved.

No broad manufacturer copay card is available for phentermine. The Adipex-P copay program was discontinued February 1, 2024. Third-party discount cards (GoodRx, SingleCare) reduce the generic to $10–$40. Some states restrict coupons on DEA Schedule IV controlled substances; confirm Pennsylvania's current rules. All figures are estimates; verify with your plan and pharmacy.

Do it yourself

Check YOUR exact coverage in 3 steps

General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.

  1. 1

    Check your UPMC plan for anti-obesity-medication benefit coverage

    Log into myUPMC or UPMC Health Plan's member portal with your member ID and search for phentermine in the drug-search tool. If no coverage appears, your plan likely has an AOM carve-out. Confirm with UPMC member services (1-888-876-2756 for commercial) or your HR department. Note that PA Medicaid cut adult weight-loss GLP-1 coverage in 2025 — check the current PA HealthChoices PDL if you have UPMC for You.

  2. 2

    Talk to your prescriber about the Schedule IV and short-term-use requirements

    Phentermine is a DEA Schedule IV controlled substance approved for approximately 12 weeks. Your prescriber must document your BMI and any qualifying comorbidities for a PA. Discuss whether phentermine is the right short-term option or whether a longer-term weight-management approach (GLP-1, lifestyle program) is preferable given Pennsylvania's tightening AOM coverage environment.

  3. 3

    Use the cash route if excluded — the generic is $10–$40

    If UPMC excludes phentermine, the cash path is straightforward: ask your prescriber for a phentermine prescription and present a GoodRx or SingleCare coupon at your pharmacy. The generic typically runs $10–$40 per month. Verify whether Pennsylvania permits coupon use for Schedule IV controlled substances before using one.

If it's denied

Options if UPMC Health Plan won't cover Phentermine (Adipex-P / Lomaira)

A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.

Qsymia generic (phentermine/topiramate ER) — launched 2025

A generic phentermine/topiramate ER entered the market in 2025 (Teva), available for approximately $63 with a coupon. It combines phentermine with topiramate, offering longer-term use than standalone phentermine, but requires a REMS program and carries teratogenic risk from topiramate.

Contrave (naltrexone/bupropion) — CurAccess ~$99/month

Contrave is another oral anti-obesity agent, but it has no generic. The Currax CurAccess cash program offers it at approximately $99 per month — still significantly more than phentermine's generic.

Weight-loss GLP-1s (Wegovy, Zepbound) — if covered

GLP-1 weight-loss agents may offer greater long-term efficacy. However, PA Medicaid in Pennsylvania dropped adult GLP-1 coverage in 2025 and commercial plans frequently exclude them. Verify benefit eligibility before pursuing a GLP-1 PA at UPMC.

These options are listed for information only — your own clinician decides what is appropriate for you.

Frequently Asked Questions

UPMC Health Plan covers phentermine only if your plan includes a weight-loss or anti-obesity-medication benefit. Employer-sponsored plans frequently carve out AOM coverage, and Medicare Part D excludes it by statute. Pennsylvania Medicaid dropped adult weight-loss GLP-1 coverage in 2025, making the state's AOM landscape more restrictive. Because the generic costs just $10–$40 cash, most patients find cash payment faster than a coverage appeal. Verify on UPMC's member drug-search tool.

Pennsylvania Medicaid dropped adult weight-loss GLP-1 coverage in 2025. Phentermine is a non-incretin oral agent and may be treated differently on the PA HealthChoices preferred drug list — some state Medicaid programs retain cheap oral AOM agents even after cutting GLP-1s. However, coverage is not guaranteed. Check the current PA HealthChoices PDL or contact UPMC for You member services directly to confirm phentermine's current formulary status.

No. Medicare Part D statutorily excludes phentermine and all other agents prescribed for weight loss. This applies to all UPMC Medicare Advantage and Part D plans. Phentermine is not included in the 2026 Medicare GLP-1 Bridge. For Medicare beneficiaries enrolled in UPMC Medicare Advantage, the generic at $10–$40 cash is the only realistic route; manufacturer copay cards are prohibited under federal rules.

Yes — some UPMC plans apply step-therapy requiring a documented phentermine or Contrave trial before approving a weight-loss GLP-1 like Wegovy or Zepbound. However, given that Pennsylvania Medicaid dropped adult GLP-1 coverage in 2025 and commercial carve-outs are common, GLP-1 approval pathways are narrow in Pennsylvania. Confirm step-therapy requirements with UPMC member services and your prescriber before beginning a phentermine course for this purpose.

Generic phentermine costs approximately $40 per month at retail, and as low as $10 per month with a GoodRx or SingleCare discount coupon at most Pennsylvania pharmacies. No broad manufacturer copay program exists — the Adipex-P program was discontinued in February 2024. Some states restrict coupons on DEA Schedule IV controlled substances; verify Pennsylvania's current rules with your pharmacist before presenting a coupon.

The Curex GLP-1 program

If UPMC excludes phentermine, a weight-management path that skips insurance is available

Phentermine's short-term Schedule IV profile is not the right fit for everyone, and Pennsylvania's coverage landscape has tightened. Curex offers compounded semaglutide from $49/month and compounded tirzepatide from $149/month at getcurex.com/cl/glp — no insurance required, no prior authorization. Compounded semaglutide and tirzepatide are not the same medication as phentermine (Adipex-P / Lomaira). Prescription required, subject to provider review.

Compounded semaglutide
from$49/mo
Weekly injection or oral tablet
Compounded tirzepatide
from$149/mo
Injection or oral tablet
  • Medication + free shipping
  • 24/7 provider access
  • Medical intake & prescription review
From $49/moNo insurance requiredNo prior auth
Build your personalized planPrescription required, subject to provider review.

Compounded semaglutide and tirzepatide are not the same medications as Phentermine (Adipex-P / Lomaira) and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.

This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with UPMC Health Plan before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Phentermine (Adipex-P / Lomaira) and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.

Weight care with Curex

If UPMC excludes phentermine, a weight-management path that skips insurance is available

Build your personalized plan

Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.